May 03, 2016
A group of six generic-drug makers, including Allergan PLC and Mylan Pharmaceuticals Inc., were hit with a proposed class action in Pennsylvania federal court Monday accusing them of engaging in a conspiracy to dramatically raise and fix prices for two medications deemed "essential" by the World Health Organization.